Bebo Health (XPAR:MLBBO) Total Stockholders Equity: €15.72 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:MLBBO Bebo Health SA XPAR:MLBBO
48 GF Score
Price €0.18
GF Value €0.03
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Bebo Health Total Stockholders Equity?

Bebo Health XPAR:MLBBO 48 Total Stockholders Equity is €15.72 Mil as of Dec. 2025. GuruFocus rates XPAR:MLBBO with a GF Score™ of 48/100 and a GF Value™ of €0.03 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Bebo Health's Total Stockholders Equity for the quarter that ended in Dec. 2025 was €15.72 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Bebo Health's Book Value per Share for the quarter that ended in Dec. 2025 was €0.02. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Bebo Health's Debt-to-Equity for the quarter that ended in Dec. 2025 was 0.12.


Bebo Health  (XPAR:MLBBO) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Bebo Health's Book Value per Share for the quarter that ended in Dec. 2025 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Bebo Health's Debt-to-Equity for the quarter that ended in Dec. 2025 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bebo Health Total Stockholders Equity Related Terms


Bebo Health Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Bebo Health's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bebo Health Total Stockholders Equity Chart

Bebo Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial 0.50 8.14 8.53 8.63 15.72

Bebo Health Semi-Annual Data
Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity Get a 7-Day Free Trial 0.50 8.14 8.53 8.63 15.72
XPAR:MLBBO
48GF Score
Bebo Health SA XPAR:MLBBO
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of €15.72 Mil mean?
Bebo Health (XPAR:MLBBO) has a Total Stockholders Equity of €15.72 Mil as of Dec. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Bebo Health and its competitors.
Is Bebo Health's Total Stockholders Equity too high?
Bebo Health's current Total Stockholders Equity is €15.72 Mil. Overall, Bebo Health has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bebo Health's Total Stockholders Equity compare to CASY and WSM?
Bebo Health's Total Stockholders Equity of €15.72 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Retail - Cyclical company?
A good Total Stockholders Equity depends on the Retail - Cyclical industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Bebo Health and its competitors. Bebo Health's current Total Stockholders Equity is €15.72 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bebo Health stock overvalued right now?
Based on GuruFocus' analysis, Bebo Health (XPAR:MLBBO) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.03, compared to a current price of €0.18 — trading 513.3% above its estimated fair value. The current Total Stockholders Equity is €15.72 Mil. Bebo Health's overall GF Score™ is 48/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Bebo Health (XPAR:MLBBO), the current Total Stockholders Equity is €15.72 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bebo Health (XPAR:MLBBO) Overvalued in 2026?

Based on GuruFocus' analysis, Bebo Health stock appears to be overvalued. The current stock price of €0.18 is trading 513.3% above its estimated GF Value™ of €0.03. GuruFocus considers Bebo Health to be Significantly Overvalued.

Key valuation signals for XPAR:MLBBO:

  • Total Stockholders Equity: €15.72 Mil
  • GF Value™: €0.03 vs. price of €0.18 (513.3% above fair value)
  • GF Score™: 48/100 with 3 warning signs

No single metric tells the full story. See the XPAR:MLBBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bebo Health Business Description

Address 1 Rue de la Cite, Geneve, CHE, 1204
Bebo Health SA is a multilingual e-commerce portal specializing in products dedicated to health, sport and wellness.
48GF Score

Get the complete analysis for XPAR:MLBBO

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.18
Price
€0.03
GF Value